Amarin Corp Plc (AMRN)

[rosemountbomber]

Saw this post on ST by Logical95. Not a member there so I can't post a reply to him/her but it is still worth exploring here:

Usually sometimes I look at AUPH and compare them to us as I used to be in AUPH a few years back for their kidney drug and they are also a small pharma like us looking for a BO. Their management sucks too but how are they at almost $10 a share and we are sitting at 1.20!? Doesn't make sense it's infuriating. Last year total revs were 134 million and they did only 28 million of revs in the 4th quarter 2022. We did 90 million in 4th quarter 2022 and about 370 million for the year. So why the huge disrcrepancy in share price? Fair value for us right now is about 5-7 dollars. We are basically trading at our cash on hand, inventory and IP. No future potential or revenues taken into account by Wall St. it seems.

I personally have some shares in AUPH and am well aware of their story. To me, the answer to this person's question strictly lies in the fact that V has been usurped by Generics here in the U.S. Of course taking so long and with so much difficulty to get sales in the EU is not mitigating that situation either. Our stock price had drifted down to 13 just before the DuDisaster. Obviously there were some holders of Amarin that were much smarter than me as they liquidated their long positions in the weeks leading up to the DuDisaster. Without that dagger to the heart decision, the stock would have risen from the $13 level and never looked back.